BioCorRx Inc. (BICX)

[Madkins]

Los Angeles, March 18, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc. ('the
Company") (OTCQB: BICX), a leader in addiction treatment and
rehabilitation programs, announced it has entered into a letter of
intent to sell the exclusive license and distribution rights of its
Start Fresh Program to Fresh
Start Private Midwest, LLC ("Midwest").  Under the terms of
the pending agreement, Midwest will agree to pay BioCorRx, Inc. an
upfront license fee plus an ongoing upfront fee per program order
in the states of Minnesota, Missouri, and Oklahoma.  The combined population of these states is over
15 million people, many of which can benefit from the Start Fresh
Program.  Minnesota for instance, has been ranked third in a
list of states with the highest percentage of residents dependent
on alcohol by the Substance Abuse and Mental Health Services
Administration, an agency within the Federal Department of Health
and Human Services.  This pending agreement creates the
potential to help countless families in all three states suffering
from the ill effects of this deadly disease, the worst of which are
fatalities due to overdose and impaired driving.  According to
the Centers for Disease Control, Oklahoma ranks as one of the
highest states for prescription drug overdose deaths in the
nation.  Furthermore, the FDA has recently approved of a
new pure hydrocodone painkiller that is
presumably going to increase the already
abysmal addiction and overdose rates nationwide. 
Impaired driving deaths are not only tragic, but cost Missouri
taxpayers approximately $1.4 billion annually.
 Bringing the Start Fresh Program to these three new
states will positively impact families while creating a broader
revenue stream for BioCorRx, Inc.



"We are pleased about this pending deal for several
reasons.  A wider footprint throughout the Midwest expands our
reach and increases revenues in a well-populated area" said Kent
Emry, CEO of BioCorRx, Inc. "This is an indication of the
potential of the Start Fresh Program to quickly become a national
household brand when it comes to recovery from these debilitating
addictons. Furthermore, FSP Midwest currently operates in
Nebraska and we are pleased with their operations and
representation of our program thus far."Recent Mediahttps://vimeo.com/88412943http://ehealthradio.podbean.com/2014/02/22/biocorrx-inc-the-treatment-of-alcoholism-with-its-revolutionary-start-fresh-program/http://thestockradio.com/ceyyfresh-start-private-management-inc-coo-brady-granier/https://vimeo.com/85537808https://vimeo.com/84401532http://vimeo.com/m/84960767http://www.thedoctorstv.com/videolib/init/10691About BioCorRxBioCorRx, Inc. (OTCQB: BICX) is an addiction
treatment and rehabilitation company on the leading edge of
substance abuse addiction treatment. The company has developed a
highly effective program called the Start Fresh
ProgramTM consisting of two components used by various
addiction clinics in the US. Clinic reports show that the treatment
program has an 85% success rate with individuals that complete the
program. The first component of the program consists of an
outpatient implant procedure performed by a licensed physician that
delivers therapeutic levels of the drug Naltrexone, an opioid
antagonist that significantly reduces physical cravings for alcohol
and opioids, into the body. The second component of the program
developed by BioCorRx is a one on one coaching program specifically
tailored for the treatment of alcoholism and other substance abuse
addictions. For more information on BICX, visit www.BioCorRx.comSafe Harbor
StatementThe information in this release includes
forward-looking statements. These forward-looking statements
generally are identified by the words "believe," "project,"
"estimate," "become," "plan," "will," and similar expressions.
These forward-looking statements involve known and unknown risks as
well as uncertainties, including those discussed in the following
cautionary statements and elsewhere in this release. Although the
Company believes that its expectations are based on reasonable
assumptions, the actual results that the Company may achieve may
differ materially from any forward-looking statements, which
reflect the opinions of the management of the Company only as of
the date hereof. CONTACT: Investor Relations
Maximum Performance Advisors, Inc.
858-381-4677

http://www.otcdynamics.com/biocorrx-inc-executes-letter-of-intent-to-sell-rights-for-the-start-fresh-program-in-minnesota-missouri-and-oklahoma